financetom
Business
financetom
/
Business
/
Check Point Software Completes Acquisition of Cyberint Technologies
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Check Point Software Completes Acquisition of Cyberint Technologies
Oct 2, 2024 10:16 PM

10:15 AM EDT, 10/01/2024 (MT Newswires) -- Check Point Software Technologies ( CHKP ) said Tuesday it completed the acquisition of Cyberint Technologies.

Financial terms were not disclosed.

Check Point said it will offer Cyberint's key capabilities within its Infinity platform and managed services.

Price: 190.94, Change: -1.87, Percent Change: -0.97

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pool Q1 Adjusted EPS, Sales Decline, Trail Consensus Views; Guides 2024 Earnings In-Line
Pool Q1 Adjusted EPS, Sales Decline, Trail Consensus Views; Guides 2024 Earnings In-Line
Apr 25, 2024
09:30 AM EDT, 04/25/2024 (MT Newswires) -- Pool Corp. ( POOL ) on Thursday reported Q1 adjusted net income of $1.85 per diluted share, compared with $2.46 a year earlier. Analysts polled by Capital IQ expected $1.93. Revenue for the quarter ended March 31 was $1.12 billion, down from $1.21 billion a year earlier. Analysts expected $1.13 billion. For 2024,...
EMCOR Group's Q1 Earnings, Revenue Increase; Raises 2024 Guidance
EMCOR Group's Q1 Earnings, Revenue Increase; Raises 2024 Guidance
Apr 25, 2024
09:31 AM EDT, 04/25/2024 (MT Newswires) -- EMCOR Group ( EME ) reported Q1 earnings Thursday of $4.17 per diluted share, up from $2.32 a year earlier. Analysts polled by Capital IQ expected $2.97. Revenue for the quarter ended March 31 was $3.43 billion, up from $2.89 billion a year earlier. Analysts surveyed by Capital IQ expected $3.23 billion. For...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Apr 25, 2024
April 25 (Reuters) - GlaxoSmithKline sued Pfizer ( PFE ) and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines. GSK said in the lawsuit that Pfizer ( PFE ) and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed more...
International Paper's Shares Fall After Lower Q1 Adjusted Earnings, Net Sales
International Paper's Shares Fall After Lower Q1 Adjusted Earnings, Net Sales
Apr 25, 2024
09:37 AM EDT, 04/25/2024 (MT Newswires) -- International Paper ( IP ) shares were down 2.7% in early Thursday trading after the company reported Q1 adjusted operating earnings of $0.17 per diluted share, down from $0.53 a year earlier. Analysts polled by Capital IQ expected $0.22. Net sales for the quarter ended March 31 were $4.62 billion, down from $5.02...
Copyright 2023-2026 - www.financetom.com All Rights Reserved